| Q91989874 | A model of functional thyroid disease status over the lifetime |
| Q55331831 | Association between perfluoroalkyl substances exposure and thyroid function in adults: A meta-analysis. |
| Q36456151 | Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010 |
| Q58080051 | Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort |
| Q35119347 | Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants |
| Q38716034 | Cosmetics as endocrine disruptors: are they a health risk? |
| Q37077698 | Cross-Sectional Associations of Serum Perfluoroalkyl Acids and Thyroid Hormones in U.S. Adults: Variation According to TPOAb and Iodine Status (NHANES 2007-2008). |
| Q93123912 | Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice |
| Q50940268 | Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility. |
| Q38960407 | Exposure to perfluorinated compounds: in vitro study on thyroid cells. |
| Q89349832 | Exposure to perfluoroalkyl substances and associations with serum thyroid hormones in a remote population of Alaska Natives |
| Q66629762 | Food additives and child health: technical report |
| Q92633952 | Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q47806217 | Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study |
| Q96955204 | Per- and poly-fluoroalkyl substances and bone mineral density: Results from the Bayesian weighted quantile sum regression |
| Q38711850 | Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community |
| Q50041743 | Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study |
| Q35562877 | Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women |
| Q34749100 | Perfluoroalkyl substances and thyroid function in older adults |
| Q39262970 | Perfluoroalkyl substances exposure and thyroid hormones in humans: epidemiological observations and implications. |
| Q38728291 | Perfluorooctanoic acid induces mitochondrial dysfunction in MC3T3-E1 osteoblast cells |
| Q36602609 | Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study |
| Q44964762 | Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children |
| Q36453518 | Regional Variation in Human Exposure to Persistent Organic Pollutants in the United States, NHANES. |
| Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
| Q35790907 | Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011-2012. |
| Q54993802 | Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA). |
| Q28397401 | The effects of environmental chemicals on renal function |
| Q30241400 | Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). |